Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.
J Immunother Cancer. 2021 Dec;9(12):e003334. doi: 10.1136/jitc-2021-003334.
J Immunother Cancer. 2021.
PMID: 34873013
Free PMC article.